News and Trends 18 Jul 2023 Korro Bio and Frequency Therapeutics to merge …programs Korro Bio’s wholly owned, early-stage pipeline targets several diseases, such as Parkinson’s disease, severe alcoholic hepatitis, amyotrophic lateral sclerosis, subsets of pain, and cardiometabolic disease. About Frequency Therapeutics Headquartered… July 18, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Mar 2023 5 women leading the way in biotech …for the treatment of central nervous system (CNS) disorders including therapies for schizophrenia and Parkinson’s disease. She believes that there is plenty of scope in polypharmacology, which is the use… March 8, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 23 May 2019 Irish Life Sciences VC Raises €118M Fund with European Focus …acquired in 2014 and received approval for its inhalable Parkinson’s drug Inbrija in 2018. Picture via Fountain Healthcare Partners; from left to right, partners Aidan Kind, Manus Rogan and Ena… May 23, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jun 2023 How AI can advance research and treatment of CNS disorders …generation of treatments for diseases such as Alzheimer’s, Parkinson’s, and ALS. AI is revolutionizing drug discovery for CNS disorders AI has transformed the drug discovery process for CNS disorders by… June 13, 2023 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 31 Mar 2022 Precision Medicine Startups Increase Focus on Data Access and Privacy …long-term or chronic conditions such as long Covid, multiple sclerosis, and Parkinson’s or Alzheimer’s disease. Research participants receive free home DNA kits that allow them to easily take part in… March 31, 2022 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
Sponsored by MC Services 10 Mar 2023 Meet some of the biotechs attending Bio-Europe Spring 2023 …already proven once that it can bring a new compound successfully through the development and to the market: Xadago, Newron’s treatment for Parkinson’s disease, a condition that affects the nerve… March 10, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 9 Aug 2018 Modulating the Microbiome Could Boost Vaccine Performance Dutch scientists have found that altering a patient’s microbiome with antibiotics before a vaccination can boost the body’s resulting immune response against rotavirus infection. Rotavirus causes severe vomiting and diarrhea… August 9, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email